Medscape Conference Coverage, based on selected sessions at the:

American Society for Clinical Pathology (ASCP) 2008 Annual Meeting

October 16 - 19, 2008; Baltimore, Maryland

This activity was developed in cooperation with the American Society for Clinical Pathology. Conference news does not receive grant support and is produced independently.

Conference News

  • Molecular-Friendly Surgical Pathology

    Using a combination of rapid-tissue processing and a universal molecular fixative for long-term tissue preservation is less time-consuming, more cost-effective, helps retain tissue histomorphology, and will eventually allow for tailor-made approaches to disease prognostication and treatment.
    Medscape Medical News, October 22, 2008
  • Combined Colposcopy, HPV Testing, Cytology

    This study evaluated 189 women using simultaneous colposcopy and biopsy, endocervical brush cytology, and polymerase chain reaction (PCR)-human papillomavirus (HPV) testing. Of these, 142 tested positive for cervical intraepithelial neoplasia 1, squamous intraepithelial lesions, or high-risk HPV. The management of 11 would have been altered on the basis of contemporaneous endocervical brushing and HPV testing.
    Medscape Medical News, October 21, 2008
  • Mediastinoscopy for Granulomatous Inflammation in Lymph Nodes

    A review of 76 cases of granulomatous inflammatory disease in the mediastinum shows the importance of fully characterizing granulomas, even when identified as sarcoidosis, to prevent misdiagnosis.
    Medscape Medical News, October 20, 2008
  • MicroRNA Profiles Distinguish Renal Cell Carcinomas

    The expression profiles of 25 micro (mi)RNAs of chromophobe renal cell carcinoma (CHRCC), papillary renal cell carcinoma (PRCC), and clear cell carcinoma (CCRCC) were analyzed. A total of 7 miRNAs in CCRCC were upregulated, as were 9 in PRCC, and 20 in CHRCC.
    Medscape Medical News, October 20, 2008
  • Endothelial Dysfunction and Metabolic Syndrome

    This study of 45 patients with metabolic syndrome and 20 healthy subjects, who were evaluated noninvasively with high-resolution ultrasound imaging, shows that high-density lipoprotein accounts for 66.4% predictability in terms of future cardiovascular risk.
    Medscape Medical News, October 20, 2008

The materials presented here do not reflect the views of Medscape or those of the ASCP. These materials may discuss uses and dosages for therapeutic or diagnostic products or procedures that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic or diagnostic product or procedure discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies, tests, or procedures described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication or an educational activity of the American Society for Clinical Pathology.